We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Mice Protected by Vaccine Based on Genetically Weakened Pneumonia Bacteria

By LabMedica International staff writers
Posted on 10 Mar 2011
By introducing a mutation into the bacterial gene that codes for the virulence factor pneumolysin, a research team has created a potential new vaccine to protect against pneumococcal pneumonia caused by Streptococcus pneumoniae.

Pneumolysin is a 53-kDa pore-forming toxin composed of 471 amino acids. More...
It has a range of biological activities including the ability to lyse and interfere with the function of cells and soluble molecules of the immune system. Secreted pneumolysin aids the bacteria during colonization, by facilitating adherence to the host, during invasion by damaging host cells, and during infection by interfering with the host immune response.

Investigators at the Albert Einstein College of Medicine (New York, NY, USA) used a previously described method of controlling gene expression with computer-based gene design and de novo DNA synthesis to attenuate the virulence of Streptococcus pneumoniae. They produced two weakened S. pneumoniae serotype 3 (SP3) strains in which the pneumolysin gene (ply) was recoded with underrepresented codon pairs while retaining its amino acid sequence.

Results of studies conducted with these modified strains were published in the February 21, 2011, online edition of the Journal of Infectious Diseases. They revealed that expression of ply and production of pneumolysin by the recoded SP3 strains were decreased, and the recoded SP3 strains were less virulent in mice than the wild-type SP3 strain or a delta-ply SP3 strain. The least virulent recoded strain induced a markedly reduced inflammatory response in the lungs compared with the wild type or delta-ply strain. Despite the reduced inflammatory response engendered by the mutated bacteria, an immune response was generated that protected the mice from subsequent challenge with the wild-type strain of S. pneumoniae.

"Our idea was to design a live vaccine that would stimulate the immune system sufficiently to ward off disease but would not lead to the severely damaging inflammatory response that this strain can cause,” said first author Dr. J. Robert Coleman, a postdoctoral fellow in microbiology and immunology at the Albert Einstein College of Medicine. "The novelty of this approach lies in the fact that the gene's expression would be reduced, but not eliminated. Previous approaches to genetic regulation of virulence relied on knocking out genes, which eliminates their expression completely.”

Related Links:

Albert Einstein College of Medicine





Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
New
Gastrointestinal Panel
Xpert® GI Panel
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: 123RF

Screening After Pneumococcal Disease May Reveal Undiagnosed Blood Cancer or Immune Disorders

Severe pneumococcal disease requiring hospitalization often presents as pneumonia, particularly in older adults and people with cancer or compromised immune function. Because M protein testing and antibody... Read more

Microbiology

view channel
Image Credit: 123RF

FDA-Cleared Multiplex PCR Test Detects 13 Respiratory Pathogens in a Single Sample

Respiratory tract infections can be difficult to distinguish at presentation because many cause overlapping, nonspecific symptoms and are initially grouped as influenza-like illnesses. Causes span a range... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.